sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
26-Nov-2014 04:00
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 576-600 out of 936.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>

Public Release: 1-Oct-2013
TWAS 24th General Meeting
Bangladeshi immunologist Firdausi Qadri awarded the C.N.R. Rao Prize
Firdausi Qadri has been selected for significant contributions she gave to the field in almost 30 years of work on enteric diseases, and for her studies aimed at developing new strategies for mass immunization against some common infectious disease in developing countries, particularly in Bangladesh.

Contact: Ed Lempinen
elempinen@twas.org
39-348-920-1915
TWAS

Public Release: 1-Oct-2013
American Journal of Respiratory and Critical Care Medicine
ATS and ERS publish policy statement on disparities in respiratory health
To address the global phenomenon of disparities in respiratory health, the American Thoracic Society and the European Respiratory Society have released an official policy statement in which each pledges its commitment to reducing health disparities between the lowest and highest socioeconomic groups by continuing or initiating work with leaders from governments, academia, and other organizations to promote scientific inquiry and training, disseminate medical information and best practices, and monitor and advocate for public respiratory health.

Contact: Nathaniel Dunford
ndunford@thoracic.org
American Thoracic Society

Public Release: 30-Sep-2013
European Cancer Congress
The State of Oncology 2013
A proposal for a new financing model to tackle the major disparities that exist in the prevention, diagnosis, treatment and outcome of cancer in countries worldwide has been presented at the 2013 European Cancer Congress. While much progress has been made against cancer over the last century, a new report brings together evidence that not every patient benefits from it, nor even has the opportunity to benefit.
International Prevention Research Institute, World Prevention Alliance, and others

Contact: Mary Rice
mary.rice@riceconseil.eu
ECCO-the European CanCer Organisation

Public Release: 29-Sep-2013
Lancet Global Health
Avahan Aids initiative may have prevented 600,000 HIV infections in India over 10 years
A program funded by the Bill & Melinda Gates Foundation may have saved around 600,000 people in India from becoming infected with HIV over the course of a decade, according to a new report.
Bill & Melinda Gates Foundation

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London

Public Release: 26-Sep-2013
NIH expands Vaccine and Treatment Evaluation Units
A nationwide group of institutions that conducts clinical trials of promising candidate vaccines and therapies for infectious diseases, known as the Vaccine and Treatment Evaluation Units, has been awarded nine contracts to strengthen and broaden the scope of its research. Group Health Research Institute is one of these institutions.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute

Public Release: 26-Sep-2013
68th Brazilian Congress of Cardiology
European and Brazilian cardiology societies team up to tackle cardiovascular disease
As the European Society of Cardiology and the Brazilian Society of Cardiology team up to deliver key cardio messages at the 68th BSC Congress in Rio de Janeiro (28 September to 1 October 2013), new research underscores the essential role of cardiology specialists in Brazil.

Contact: ESC Press Office
press@escardio.org
33-049-294-8627
European Society of Cardiology

Public Release: 25-Sep-2013
Innovations save lives of mothers and children
Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015. Right now the annual global death toll of mothers and children under 5 is 6.9 million. Between 2016-2020, these innovations have the potential to save the lives of nearly 7.5 million women and children.

Contact: Marshall Hoffman
marshall@hoffmanpr.com
703-533-3535
Hoffman & Hoffman Worldwide

Public Release: 24-Sep-2013
Pfizer Pharmaceuticals supports MARC project
The Council on Health Research for Development is pleased to acknowledge the support of Pfizer Pharmaceuticals on Phase II of the Mapping African Research Ethics Review and Medicines Regulatory Capacity project.
Pfizer Pharmaceuticals

Contact: Teresa Cullen
cullen@cohred.org
41-225-918-900
COHRED

Public Release: 23-Sep-2013
Clinical Infectious Diseases
CDC, Mass. General study reveals that preventing malaria in travelers to West Africa reduces health costs
Not only do US travelers to West Africa who consult health providers before they leave and take prescribed preventive medications substantially reduce their risk of contracting malaria, they also reduce costs to their health insurance providers and, in most cases, to themselves.
US Centers for Disease Control and Prevention

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Public Release: 23-Sep-2013
New investment fund will advance late-stage vaccines, other global health technologies
A new $95 million international investment fund will for the first time allow individual and institutional investors the opportunity to finance late-stage global health technologies and advance interventions to fight such challenges in low-income countries as malaria, tuberculosis, HIV/AIDS and maternal and infant mortality.

Contact: Colleen Harris
colleen@colleenharris.co.uk
44-207-223-4512
Grand Challenges Canada

Public Release: 23-Sep-2013
Proceedings of the National Academy of Sciences
Cancer-killing cells controlled by epigenetic process, new study shows
Natural killer cells are white blood cells that can kill and contain cancer and infectious diseases. USC scientists have identified a specific enzyme that controls the development of natural killer cells in the body. Understanding how that enzyme affects the natural killer cell may help focus future drug development in the fight against cancer.
National Institutes of Health, Leukemia and Lymphoma Society

Contact: Alison Trinidad
alison.trinidad@usc.edu
323-442-3941
University of Southern California - Health Sciences

Public Release: 19-Sep-2013
American Society of Clinical Pathology 2013 Annual Meeting in Chicago
New test enables early diagnosis of liver cancer
Researchers have found a way to make early liver cancer show its true colors.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 18-Sep-2013
University of Maryland researchers studying vaccine to prevent potential bird flu pandemic
Scientists at the University of Maryland School of Medicine's Center for Vaccine Development are part of nationwide vaccine research aimed at protecting adults from a new and virulent strain of avian influenza virus. The virus, called H7N9 influenza virus, emerged in China last spring. The study, sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will help prepare for the possibility of a global pandemic.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Bill Seiler
bseiler@umm.edu
410-328-8919
University of Maryland Medical Center

Public Release: 18-Sep-2013
School of Public Health receives $390,000 grant to study alcohol use among youth acquiring HIV
Dr. Monica Swahn, professor in the School of Public Health and associate vice president for research at Georgia State University, has received a two-year, $390,000 grant from the National Institutes of Health to study the role of alcohol marketing and early alcohol use among African youth acquiring HIV.
National Institutes of Health

Contact: Frances Marine
francesmarine@gsu.edu
404-413-1504
Georgia State University

Public Release: 18-Sep-2013
Nature Communications
Scientists develop a new way to identify good fat
When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at the University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.
National Institutes of Health

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 18-Sep-2013
NIH prepares by funding new bird flu vaccine studies
Group Health Research Institute scientists are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China earlier this year, joining seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health to test vaccines to protect against the illness in adults. "Influenza viruses are constantly changing," said Lisa Jackson, M.D., M.P.H., a senior investigator at Group Health Research Institute.
National Institutes of Health

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute

Public Release: 18-Sep-2013
Journal of Infectious Diseases
Chronic inflammation of blood vessels could help explain high childhood mortality in malaria regions
Recurrent episodes of malaria cause chronic inflammation in blood vessels that might predispose to future infections and may increase susceptibility to cardiovascular disease, a Wellcome Trust study in Malawian children finds.
Wellcome Trust

Contact: Jen Middleton
j.middleton@wellcome.ac.uk
44-207-611-7262
Wellcome Trust

Public Release: 17-Sep-2013
WINFOCUS brings space station ultrasound from orbit to the ends of the Earth
Techniques developed for use aboard the International Space Station to provide remote imaging for health diagnostics are being adapted and used for people living in isolated, underdeveloped areas far from any hospital, where CT scans, MRIs and even simple X-ray exams are impossible.

Contact: Laura Niles
Laura.E.Niles@nasa.gov
281-244-7069
NASA/Johnson Space Center

Public Release: 17-Sep-2013
BioMed Central Public Health
Virginia Tech researchers help people in remote Africa respond to diarrheal disease
Researchers with Virginia Tech and the University of Florida undertook a study of diarrheal disease outbreaks in Botswana that relied only on the use of a simple questionnaire and existing hospital staff and infrastructure. The approach does not require increased human or economic resources, and it can give immediate insight into public health threats and disease outbreaks where this type of information otherwise would not be acquired.
National Science Foundation

Contact: Lynn Davis
davisl@vt.edu
540-231-6157
Virginia Tech

Public Release: 16-Sep-2013
Clinical Reviews in Allergy and Immunology
Gut microbes closely linked to proper immune function, other health issues
A new understanding of the essential role of gut microbes in the immune system may hold the key to dealing with some of the more significant health problems facing people in the world today, Oregon State University researchers say in a new analysis.

Contact: Dr. Natalia Shulzhenko
Natalia.shulzhenko@oregonstate.edu
541-737-1051
Oregon State University

Public Release: 16-Sep-2013
ChipCare's handheld analyzer attracts one of Canada's largest-ever healthcare angel investments
An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada's healthcare sector. Phase II financing has closed, with an investment of CDN $2.05M to support ChipCare's continuing development and commercialization over the next three years.

Contact: Zina Nelku
zina.nelku@grandchallenges.ca
647-627-0195
Grand Challenges Canada

Public Release: 16-Sep-2013
Environmental Health Perspectives
Study shows projected climate change in West Africa not likely to worsen malaria situation
MIT study combines a new model of malaria transmission with global forecasts for temperature and rainfall to improve predictions of malaria with climate change.
National Science Foundation

Contact: Denise Brehm
brehm@MIT.EDU
617-253-8069
Massachusetts Institute of Technology

Public Release: 12-Sep-2013
American Heart Association High Blood Pressure Research Scientific Sessions 2013
Simple steps may identify patients that hold onto excess sodium
Getting a second urine sample and blood pressure measure as patients head out of the doctor's office appears an efficient way to identify those whose health may be in jeopardy because their bodies hold onto too much sodium, researchers report.
National Institutes of Health

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 12-Sep-2013
PLOS ONE
Research treats the fungus among us with nontoxic medicinal compound
A Kansas State University research team has found a breakthrough herbal medicine treatment for a common human fungal pathogen that lives in almost 80 percent of people. The team discovered a medicinal herb called Gymnema slyvestre is both nontoxic and blocks the virulence properties of a common fungus called Candida albicans.
Johnson Cancer Research Center

Contact: Govindsamy Vediyappan
gvediyap@k-state.edu
785-532-1529
Kansas State University

Public Release: 12-Sep-2013
Immunity
La Jolla Institute scientist identifies helper cells that trigger potent responses to HIV
A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology. La Jolla Institute scientist Shane Crotty, Ph.D., a respected vaccine researcher and member of one of the nation's top AIDS vaccine consortiums, showed that certain helper T cells are important for triggering a strong antibody response against HIV, the virus that causes AIDS.

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Showing releases 576-600 out of 936.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>